General Biologicals Corporation (TPEX:4117)
Taiwan · Delayed Price · Currency is TWD 7.60
-0.85 (-10.06%)
Oct 20, 2026, 1:40 PM CST
General Biologicals Market Cap
General Biologicals has a market cap or net worth of 541.56 million as of October 20, 2026. It is the 38,291st most valuable company in the world and the 2,251st biggest in Taiwan. Its market cap has decreased by 40.64% in one year.
Market Cap
541.56M
Enterprise Value
2.47B
Revenue
260.23M
Global Rank
Country Rank
#2,251 Taiwan
PE Ratio
1.00
ChartMarket Cap Chart
Since February 21, 2005, General Biologicals's market cap has increased from 326.98M to 541.56M, an increase of 65.63%. That is a compound annual growth rate of 2.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2026 | 541.56M | -30.71% |
| Dec 31, 2025 | 781.59M | -38.66% |
| Dec 31, 2024 | 1.27B | -21.11% |
| Dec 29, 2023 | 1.62B | 0.37% |
| Dec 30, 2022 | 1.61B | -22.70% |
| Dec 30, 2021 | 2.08B | -35.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GeneFerm Biotechnology | 1.21B |
| InnoPharmax | 1.13B |
| Excelsior Biopharma | 1.11B |
| Anxo Pharmaceutical | 1.07B |
| Prince Pharmaceutical | 1.07B |
| DV Biomed | 874.13M |
| Mediera | 828.54M |
| Winston Medical Supply | 801.14M |